Clinical Trials Directory

Trials / Completed

CompletedNCT05749744

Effects of Cardiac Telerehabilitation During COVID-19 on Cardiorespiratory Capacities in Coronary Artery Disease Patients.

Status
Completed
Phase
Study type
Observational
Enrollment
54 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

After an acute coronary syndrome, an adapted cardiac rehabilitation program is necessary to restore or increase physical capacities and decrease cardiovascular risk. This multidisciplinary care combines physical training sessions and therapeutic education workshops. The COVID-19 pandemic imposed restrictions such as the closure of rehabilitation centres. To remedy this problem, one solution was to adapt the existing program to a remote cardiac telerehabilitation, i.e., medical and paramedical supervision of rehabilitation sessions and therapeutic patient education meetings via digital tools. Recent studies have shown that it was a safe (no reported adverse effects), effective (similar gains in peak oxygen consumption compared to traditional cardiac rehabilitation and patient-adherence alternative.

Detailed description

The hypothesis of this study is that telerehabilitation was more effective on cardiorespiratory functions.

Conditions

Interventions

TypeNameDescription
OTHERcardiac telerehabilitation program by videoconference* A video conference interview with an Adapted Physical Activity (APA) teacher before starting physical training * Exercise training for 3 weeks via distance coaching * Therapeutic patient education (TPE) workshops conducted remotely with 1 workshop per week. * Medical follow-up via teleconsultation * Psychological and/or dietetic follow-up if necessary. * Final assessment at 1 month with evaluation of aerobic metabolism, functional evaluation and final shared educational assessment (BEP). * Appointment with an association "Cœur et Santé" and "Sport-Santé 42" or setting up of an individual physical activity

Timeline

Start date
2021-03-01
Primary completion
2021-12-01
Completion
2021-12-01
First posted
2023-03-01
Last updated
2023-03-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05749744. Inclusion in this directory is not an endorsement.